Contact | Print version | PDF version | Send article | RSS-Feed

Crucell Announces STAR Research License Agreement with Toyobo Gene Analysis Co. LTD.

05 May 2008 - Crucell N.V. announced a non-exclusive STAR® research license agreement with Toyobo Gene Analysis Co. LTD. Under the agreement, Toyobo Gene Analysis will evaluate Crucell's STAR® technology for generating cell lines for the production of recombinant proteins for third-party customers. Financial details of the agreement were not disclosed. STAR® technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is effective for production of antibodies and proteins on mammalian cell lines such as Crucell's PER.C6® human cell technology and the Chinese hamster ovary (CHO) cell line.